MiR-148b has an antagonistic role with the oncomiR-214 in promoting cancer cell migration in vitro, and in vivo by modulating the expression level of the adhesion molecules integrin alpha 5 (ITGA5), and activated leukocyte cell adhesion molecule (ALCAM) [126]. This evidence concerns the gene ITGA5 and cancer.